Panel discussion and Q&A

4 More presentations in this session

Opening & welcome

Doctor P. Ridker (Boston, US)

Inflammation in stable atherosclerotic cardiovascular disease (ASCVD): what impact does it have?

Doctor P. Ridker (Boston, US)

Inflammation in acute myocardial infarction (AMI): where do we stand?

Professor R. Mehran (New York City, US)

High-sensitivity C-reactive protein: how can it guide cardiovascular risk assessment?

Professor F. Kahles (Aachen, DE)